Biotechnology
The Biotechnology industry has a total of 621 stocks, with a combined market cap of $937.2 billion and total revenue of $101.41 billion.
Market Cap
937.2B
Revenue
101.41B
Profits
-42.53B
PE Ratio
n/a
Profit Margin
-41.94%
Dividend Yield
0.05%
621 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 98.23B | - | 1,484,912 | 11.42B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.76B | 0.62% | 904,972 | 14.21B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.15B | 1.18% | 971,763 | 2.46B |
| 4 | ARGX | argenx SE | 45.46B | 0.44% | 272,782 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 37.19B | 1.02% | 112,387 | 4.56B |
| 6 | INSM | Insmed Incorporated | 30.66B | 0.19% | 2,896,264 | 398.11M |
| 7 | BNTX | BioNTech SE | 23.73B | 2.60% | 741,550 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 20.91B | -1.05% | 10,647,559 | 2.31B |
| 9 | GMAB | Genmab A/S | 17.63B | 1.13% | 745,900 | 3.65B |
| 10 | INCY | Incyte Corporation | 16.55B | -2.08% | 1,460,736 | 4.58B |
| 11 | SMMT | Summit Therapeutics Inc. | 14.19B | 1.11% | 3,721,135 | - |
| 12 | ASND | Ascendis Pharma A/S | 11.89B | -0.64% | 1,061,775 | 576.33M |
| 13 | EXEL | Exelixis, Inc. | 10.66B | -1.30% | 2,062,452 | 2.23B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 10.36B | -0.77% | 2,014,446 | 3.06B |
| 15 | MRNA | Moderna, Inc. | 10.33B | 5.23% | 16,032,612 | 3.08B |
| 16 | ROIV | Roivant Sciences Ltd. | 10.20B | -0.66% | 7,143,765 | 23.23M |
| 17 | BBIO | BridgeBio Pharma, Inc. | 9.85B | -1.58% | 2,175,943 | 235.81M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.81B | 0.03% | 224,094 | 515.55M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 9.78B | 0.57% | 2,682,881 | 944.05M |
| 20 | CAI | Caris Life Sciences, Inc. | 9.26B | 1.10% | 787,902 | 533.85M |
| 21 | VRNA | Verona Pharma plc | 9.16B | 0.22% | 1,244,235 | 221.67M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 9.16B | 0.60% | 1,620,864 | 1.18B |
| 23 | CORT | Corcept Therapeutics Incorporated | 8.43B | -0.65% | 834,626 | 716.08M |
| 24 | RVMD | Revolution Medicines, Inc. | 8.30B | 2.00% | 2,008,788 | - |
| 25 | TECH | Bio-Techne Corporation | 8.25B | -0.21% | 2,437,815 | 1.22B |
| 26 | JAZZ | Jazz Pharmaceuticals plc | 7.90B | 1.47% | 802,384 | 4.09B |
| 27 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.58B | 3.06% | 774,184 | 156.29M |
| 28 | LEGN | Legend Biotech Corporation | 6.29B | 0.21% | 911,601 | 796.84M |
| 29 | ABVX | ABIVAX Société Anonyme | 6.17B | -0.11% | 1,172,421 | 7.07M |
| 30 | RNA | Avidity Biosciences, Inc. | 6.08B | 3.12% | 2,198,244 | 10.73M |
| 31 | AXSM | Axsome Therapeutics, Inc. | 5.86B | 1.33% | 526,015 | 495.03M |
| 32 | CYTK | Cytokinetics, Incorporated | 5.77B | -0.84% | 1,951,349 | 85.74M |
| 33 | NUVL | Nuvalent, Inc. | 5.69B | 2.91% | 336,865 | - |
| 34 | CRSP | CRISPR Therapeutics AG | 5.65B | -0.35% | 2,385,811 | 38.05M |
| 35 | MTSR | Metsera, Inc. | 5.64B | 60.80% | 20,036,865 | - |
| 36 | MRUS | Merus N.V. | 5.23B | 1.42% | 482,252 | 56.23M |
| 37 | TGTX | TG Therapeutics, Inc. | 5.10B | 8.03% | 3,447,768 | 454.07M |
| 38 | PTCT | PTC Therapeutics, Inc. | 4.83B | 0.61% | 970,031 | 1.76B |
| 39 | KRYS | Krystal Biotech, Inc. | 4.79B | 1.13% | 483,063 | 359.21M |
| 40 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.43B | 4.43% | 2,249,487 | 572.98M |
| 41 | PCVX | Vaxcyte, Inc. | 4.35B | 5.42% | 2,071,033 | - |
| 42 | ACLX | Arcellx, Inc. | 4.34B | 0.46% | 275,642 | 56.98M |
| 43 | ACAD | ACADIA Pharmaceuticals Inc. | 4.14B | 0.45% | 1,792,003 | 1.02B |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 4.01B | 3.71% | 702,623 | 209.18M |
| 45 | ADMA | ADMA Biologics, Inc. | 3.83B | 0.75% | 3,183,040 | 474.17M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 3.71B | -0.61% | 1,136,272 | 429.16M |
| 47 | AKRO | Akero Therapeutics, Inc. | 3.71B | 2.63% | 867,561 | - |
| 48 | ZLAB | Zai Lab Limited | 3.69B | 1.53% | 451,714 | 427.80M |
| 49 | TLX | Telix Pharmaceuticals Limited | 3.65B | 0.70% | 141,775 | 664.23M |
| 50 | KYMR | Kymera Therapeutics, Inc. | 3.65B | 3.83% | 730,910 | 44.71M |
| 51 | AAPG | Ascentage Pharma Group International | 3.52B | -1.39% | 19,183 | 54.52M |
| 52 | MLTX | MoonLake Immunotherapeutics | 3.49B | 2.23% | 464,837 | - |
| 53 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.18B | -0.56% | 1,138,308 | 1.39M |
| 54 | CNTA | Centessa Pharmaceuticals plc | 3.13B | 2.59% | 566,205 | 15.00M |
| 55 | SRRK | Scholar Rock Holding Corporation | 3.13B | 5.64% | 3,285,540 | - |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 3.05B | 1.35% | 711,971 | 64.01M |
| 57 | MLYS | Mineralys Therapeutics, Inc. | 3.01B | -1.25% | 898,339 | - |
| 58 | SLNO | Soleno Therapeutics, Inc. | 3.01B | 3.36% | 1,967,801 | 32.66M |
| 59 | APLS | Apellis Pharmaceuticals, Inc. | 2.97B | 2.09% | 1,549,711 | 754.65M |
| 60 | VKTX | Viking Therapeutics, Inc. | 2.95B | 3.35% | 7,868,503 | - |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 2.88B | 1.08% | 867,586 | 7.50M |
| 62 | RARE | Ultragenyx Pharmaceutical Inc. | 2.83B | 4.76% | 1,600,355 | 610.16M |
| 63 | CGON | CG Oncology, Inc. | 2.82B | 0.38% | 725,025 | 551.00K |
| 64 | IMVT | Immunovant, Inc. | 2.72B | 5.48% | 1,643,026 | - |
| 65 | FOLD | Amicus Therapeutics, Inc. | 2.64B | 2.88% | 4,285,100 | 571.16M |
| 66 | IBRX | ImmunityBio, Inc. | 2.52B | -2.20% | 9,046,285 | 56.60M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.45B | 1.37% | 1,508,606 | 558.50M |
| 68 | BEAM | Beam Therapeutics Inc. | 2.40B | 0.37% | 1,867,773 | 60.27M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 2.35B | 1.15% | 721,795 | 295.52M |
| 70 | BLTE | Belite Bio, Inc | 2.34B | 1.55% | 36,101 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.27B | 0.70% | 1,376,153 | 7.00M |
| 72 | TVTX | Travere Therapeutics, Inc. | 2.27B | 2.33% | 1,626,209 | 333.87M |
| 73 | GLPG | Galapagos NV | 2.23B | -1.32% | 79,031 | 323.67M |
| 74 | CELC | Celcuity Inc. | 2.23B | 1.18% | 732,485 | - |
| 75 | APGE | Apogee Therapeutics, Inc. | 2.22B | 3.91% | 530,084 | - |
| 76 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 1.30% | 437,677 | 40.88M |
| 77 | ETNB | 89bio, Inc. | 2.21B | - | 14,388,126 | - |
| 78 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | 1.43% | 29,922,938 | 64.60M |
| 79 | IRON | Disc Medicine, Inc. | 2.14B | 1.16% | 235,643 | - |
| 80 | OCUL | Ocular Therapeutix, Inc. | 2.12B | 0.83% | 2,178,459 | 56.66M |
| 81 | ADPT | Adaptive Biotechnologies Corporation | 2.12B | 4.34% | 2,541,391 | 205.22M |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 2.08B | -0.03% | 1,058,838 | 263.47M |
| 83 | MESO | Mesoblast Limited | 2.08B | -0.94% | 328,454 | 17.20M |
| 84 | LQDA | Liquidia Corporation | 1.97B | -3.70% | 4,607,086 | 19.32M |
| 85 | DNLI | Denali Therapeutics Inc. | 1.95B | 4.47% | 2,282,593 | - |
| 86 | CDTX | Cidara Therapeutics, Inc. | 1.91B | 9.84% | 741,930 | 302.00K |
| 87 | DYN | Dyne Therapeutics, Inc. | 1.91B | 2.36% | 2,421,014 | - |
| 88 | HRMY | Harmony Biosciences Holdings, Inc. | 1.87B | -0.37% | 796,624 | 772.53M |
| 89 | NTLA | Intellia Therapeutics, Inc. | 1.85B | 10.71% | 8,914,781 | 52.86M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | 7.00% | 9,095,218 | 2.48B |
| 91 | PHVS | Pharvaris N.V. | 1.81B | -1.46% | 314,197 | - |
| 92 | COGT | Cogent Biosciences, Inc. | 1.75B | 4.51% | 1,486,247 | - |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 1.72B | 0.54% | 3,163,477 | 260.11M |
| 94 | MNKD | MannKind Corporation | 1.71B | 2.58% | 2,996,823 | 301.74M |
| 95 | IMCR | Immunocore Holdings plc | 1.68B | 1.99% | 135,836 | 356.15M |
| 96 | VERA | Vera Therapeutics, Inc. | 1.67B | 2.03% | 2,473,359 | - |
| 97 | CLDX | Celldex Therapeutics, Inc. | 1.65B | 1.02% | 1,012,689 | 5.79M |
| 98 | VCEL | Vericel Corporation | 1.61B | 0.46% | 940,255 | 249.12M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.60B | 0.62% | 607,259 | 305.00K |
| 100 | EWTX | Edgewise Therapeutics, Inc. | 1.59B | 5.89% | 886,175 | - |
| 101 | BHVN | Biohaven Ltd. | 1.57B | 3.70% | 3,541,290 | - |
| 102 | ARDX | Ardelyx, Inc. | 1.50B | 0.16% | 2,040,727 | 386.15M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.46B | 2.75% | 564,193 | 4.85M |
| 104 | ABCL | AbCellera Biologics Inc. | 1.44B | 7.10% | 5,749,503 | 32.88M |
| 105 | NVAX | Novavax, Inc. | 1.44B | 1.84% | 4,520,403 | 1.08B |
| 106 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.42B | - | 1,381,314 | -249.00K |
| 107 | JANX | Janux Therapeutics, Inc. | 1.41B | 0.26% | 503,805 | 439.00K |
| 108 | GPCR | Structure Therapeutics Inc. | 1.41B | 3.69% | 1,258,180 | - |
| 109 | RCUS | Arcus Biosciences, Inc. | 1.33B | 1.05% | 920,007 | 262.00M |
| 110 | YDES | YD Bio Limited | 1.32B | -5.21% | 23,567 | 510.36K |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 1.28B | 0.74% | 1,489,301 | 77.93M |
| 112 | XERS | Xeris Biopharma Holdings, Inc. | 1.27B | 1.81% | 1,851,917 | 246.03M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.25B | -0.22% | 779,319 | 199.89M |
| 114 | ZYME | Zymeworks Inc. | 1.24B | 1.72% | 901,866 | 122.87M |
| 115 | TRML | Tourmaline Bio, Inc. | 1.23B | 0.04% | 633,791 | - |
| 116 | CVAC | CureVac N.V. | 1.21B | 0.19% | 381,045 | 599.54M |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.20B | -0.95% | 417,485 | - |
| 118 | INVA | Innoviva, Inc. | 1.20B | -0.78% | 1,274,840 | 370.23M |
| 119 | ELVN | Enliven Therapeutics, Inc. | 1.18B | 5.06% | 423,260 | - |
| 120 | LENZ | LENZ Therapeutics, Inc. | 1.18B | -2.39% | 242,293 | 5.00M |
| 121 | PGEN | Precigen, Inc. | 1.15B | 2.67% | 5,871,659 | 4.34M |
| 122 | SION | Sionna Therapeutics, Inc. | 1.14B | 11.88% | 304,287 | - |
| 123 | NKTR | Nektar Therapeutics | 1.12B | 6.80% | 1,029,206 | 74.93M |
| 124 | NUVB | Nuvation Bio Inc. | 1.12B | 1.55% | 4,334,451 | 14.36M |
| 125 | WVE | Wave Life Sciences Ltd. | 1.10B | 0.29% | 1,451,139 | 93.95M |
| 126 | MDXG | MiMedx Group, Inc. | 1.06B | 2.42% | 468,418 | 363.77M |
| 127 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | 2.46% | 1,488,222 | - |
| 128 | ATAI | Atai Life Sciences N.V. | 1.05B | -1.41% | 3,167,826 | 2.31M |
| 129 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.05B | 5.87% | 216,418 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.04B | 4.91% | 1,478,100 | - |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.04B | 3.18% | 500,660 | 2.50M |
| 132 | PRAX | Praxis Precision Medicines, Inc. | 1.02B | 14.47% | 511,890 | 7.77M |
| 133 | PHAR | Pharming Group N.V. | 1.01B | -0.34% | 7,713 | 339.84M |
| 134 | SPRY | ARS Pharmaceuticals, Inc. | 967.51M | - | 1,628,155 | 112.34M |
| 135 | QURE | uniQure N.V. | 941.85M | -0.29% | 2,000,965 | 14.34M |
| 136 | OCS | Oculis Holding AG | 927.91M | 6.68% | 85,297 | 960.67K |
| 137 | SYRE | Spyre Therapeutics, Inc. | 923.53M | 2.76% | 608,142 | - |
| 138 | EYPT | EyePoint Pharmaceuticals, Inc. | 920.87M | 0.83% | 1,311,269 | 51.90M |
| 139 | UPB | Upstream Bio, Inc. | 897.59M | 1.65% | 322,092 | 2.72M |
| 140 | VALN | Valneva SE | 882.80M | -0.29% | 55,071 | 230.57M |
| 141 | CRMD | CorMedix Inc. | 879.72M | 0.63% | 2,817,699 | 121.48M |
| 142 | FTRE | Fortrea Holdings Inc. | 875.31M | -4.84% | 1,267,061 | 2.73B |
| 143 | SANA | Sana Biotechnology, Inc. | 851.70M | 5.18% | 3,109,087 | - |
| 144 | IMNM | Immunome, Inc. | 850.43M | 4.05% | 1,346,443 | 12.59M |
| 145 | ABUS | Arbutus Biopharma Corporation | 849.23M | 4.24% | 1,171,040 | 15.42M |
| 146 | GERN | Geron Corporation | 848.56M | 0.76% | 3,552,734 | 164.45M |
| 147 | GHRS | GH Research PLC | 839.26M | 1.50% | 121,519 | - |
| 148 | IMTX | Immatics N.V. | 832.68M | 2.24% | 410,672 | 152.82M |
| 149 | URGN | UroGen Pharma Ltd. | 832.29M | 0.22% | 1,162,716 | 94.24M |
| 150 | TNGX | Tango Therapeutics, Inc. | 828.89M | -1.97% | 2,154,459 | 24.30M |
| 151 | PROK | ProKidney Corp. | 826.93M | 4.85% | 1,328,007 | 527.00K |
| 152 | NAGE | Niagen Bioscience, Inc. | 818.38M | 3.85% | 939,409 | 116.30M |
| 153 | PHAT | Phathom Pharmaceuticals, Inc. | 817.67M | 4.73% | 586,585 | 114.04M |
| 154 | ZBIO | Zenas BioPharma, Inc. | 797.99M | 0.05% | 108,212 | 15.00M |
| 155 | KOD | Kodiak Sciences Inc. | 791.08M | 57.50% | 5,724,205 | - |
| 156 | TSHA | Taysha Gene Therapies, Inc. | 782.92M | 1.41% | 2,262,261 | 8.10M |
| 157 | RLAY | Relay Therapeutics, Inc. | 782.75M | -2.58% | 1,160,729 | 8.36M |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 767.13M | 3.41% | 9,147,718 | 241.53M |
| 159 | IVA | Inventiva S.A. | 764.53M | 6.55% | 90,437 | 14.59M |
| 160 | AVBP | ArriVent BioPharma, Inc. | 755.39M | 5.50% | 326,282 | - |
| 161 | AVXL | Anavex Life Sciences Corp. | 750.71M | 3.31% | 1,306,547 | - |
| 162 | XNCR | Xencor, Inc. | 741.05M | 0.97% | 1,812,713 | 146.93M |
| 163 | RZLT | Rezolute, Inc. | 739.20M | 5.71% | 1,083,329 | - |
| 164 | SVRA | Savara Inc. | 735.31M | -1.13% | 661,071 | - |
| 165 | VIR | Vir Biotechnology, Inc. | 732.09M | 1.74% | 892,410 | 19.00M |
| 166 | MNMD | Mind Medicine (MindMed) Inc. | 725.88M | 5.53% | 1,316,182 | - |
| 167 | GOSS | Gossamer Bio, Inc. | 718.52M | 3.61% | 4,354,158 | 40.24M |
| 168 | SEPN | Septerna, Inc. | 713.36M | 1.91% | 205,824 | 726.00K |
| 169 | TBPH | Theravance Biopharma, Inc. | 708.58M | 1.37% | 377,881 | 77.21M |
| 170 | MRVI | Maravai LifeSciences Holdings, Inc. | 702.25M | 1.85% | 1,165,654 | 219.83M |
| 171 | KURA | Kura Oncology, Inc. | 702.19M | -1.94% | 1,266,203 | 83.28M |
| 172 | DAWN | Day One Biopharmaceuticals, Inc. | 695.51M | -0.29% | 1,003,502 | 187.64M |
| 173 | TYRA | Tyra Biosciences, Inc. | 687.00M | 3.12% | 148,091 | - |
| 174 | GYRE | Gyre Therapeutics, Inc. | 678.48M | 3.03% | 64,274 | 102.19M |
| 175 | MBX | MBX Biosciences, Inc. | 671.88M | 100.00% | 28,303,510 | - |
| 176 | DNA | Ginkgo Bioworks Holdings, Inc. | 666.77M | 5.80% | 1,349,054 | 230.82M |
| 177 | KALV | KalVista Pharmaceuticals, Inc. | 661.85M | -0.53% | 875,491 | 1.43M |
| 178 | TERN | Terns Pharmaceuticals, Inc. | 659.83M | 0.13% | 813,077 | - |
| 179 | PRME | Prime Medicine, Inc. | 654.20M | 2.04% | 2,419,199 | 4.96M |
| 180 | MGTX | MeiraGTx Holdings plc | 650.82M | 7.01% | 400,040 | 37.92M |
| 181 | PVLA | Palvella Therapeutics, Inc. | 649.31M | 0.81% | 187,573 | - |
| 182 | KROS | Keros Therapeutics, Inc. | 645.79M | 2.19% | 296,212 | 232.84M |
| 183 | NRIX | Nurix Therapeutics, Inc. | 644.47M | -0.12% | 777,326 | 88.38M |
| 184 | ORKA | Oruka Therapeutics, Inc. | 642.28M | 10.29% | 582,837 | - |
| 185 | NBTX | Nanobiotix S.A. | 632.12M | 11.15% | 100,737 | -7.44M |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 617.94M | -0.78% | 994,732 | 267.92M |
| 187 | ANAB | AnaptysBio, Inc. | 599.14M | 2.69% | 457,351 | 123.16M |
| 188 | CMPX | Compass Therapeutics, Inc. | 598.79M | 2.95% | 1,950,816 | 850.00K |
| 189 | BCAX | Bicara Therapeutics Inc. | 586.55M | 2.97% | 263,145 | - |
| 190 | OLMA | Olema Pharmaceuticals, Inc. | 571.72M | 1.96% | 1,118,616 | - |
| 191 | ARCT | Arcturus Therapeutics Holdings Inc. | 571.06M | 2.79% | 683,204 | 122.12M |
| 192 | VSTM | Verastem, Inc. | 561.91M | 0.88% | 2,519,037 | 2.14M |
| 193 | ARVN | Arvinas, Inc. | 552.83M | 0.13% | 2,745,251 | 372.80M |
| 194 | ERAS | Erasca, Inc. | 504.93M | -3.26% | 651,472 | - |
| 195 | BCYC | Bicycle Therapeutics plc | 494.16M | 2.89% | 300,531 | 19.28M |
| 196 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 197 | RGNX | REGENXBIO Inc. | 457.66M | 1.91% | 420,899 | 155.78M |
| 198 | CRVS | Corvus Pharmaceuticals, Inc. | 450.06M | 2.90% | 435,885 | - |
| 199 | XOMA | XOMA Royalty Corporation | 449.18M | 1.25% | 79,181 | 44.95M |
| 200 | IMAB | I-Mab | 446.66M | 2.37% | 642,888 | 569.46K |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 446.27M | 3.65% | 1,591,788 | 62.02M |
| 202 | PRTA | Prothena Corporation plc | 446.25M | 2.73% | 511,942 | 10.34M |
| 203 | OCGN | Ocugen, Inc. | 434.10M | 3.73% | 4,336,163 | 4.75M |
| 204 | ALMS | Alumis Inc. | 431.87M | -0.48% | 401,818 | 20.06M |
| 205 | ATXS | Astria Therapeutics, Inc. | 423.83M | 6.52% | 413,317 | - |
| 206 | LXRX | Lexicon Pharmaceuticals, Inc. | 421.54M | -2.52% | 1,765,218 | 58.43M |
| 207 | PRTC | PureTech Health plc | 409.22M | 0.93% | 5,413 | 6.39M |
| 208 | GLUE | Monte Rosa Therapeutics, Inc. | 403.29M | 3.16% | 851,602 | 177.99M |
| 209 | FULC | Fulcrum Therapeutics, Inc. | 402.98M | 0.81% | 272,368 | 80.00M |
| 210 | SLDB | Solid Biosciences Inc. | 402.58M | 0.98% | 629,641 | - |
| 211 | ABSI | Absci Corporation | 402.22M | 3.07% | 3,655,663 | 4.14M |
| 212 | ETHZ | ETHZilla Corporation | 394.62M | -5.14% | 22,743,382 | - |
| 213 | INBX | Inhibrx Biosciences, Inc. | 392.84M | -1.74% | 137,590 | 1.40M |
| 214 | MNPR | Monopar Therapeutics Inc. | 392.78M | 0.58% | 71,265 | - |
| 215 | ADCT | ADC Therapeutics SA | 391.50M | 1.75% | 837,145 | 77.25M |
| 216 | ASMB | Assembly Biosciences, Inc. | 385.58M | 1.31% | 236,524 | 33.25M |
| 217 | LRMR | Larimar Therapeutics, Inc. | 383.44M | 6.67% | 2,715,589 | - |
| 218 | AURA | Aura Biosciences, Inc. | 382.66M | 1.32% | 228,126 | - |
| 219 | CGEM | Cullinan Therapeutics, Inc. | 370.99M | 1.29% | 594,776 | - |
| 220 | LCTX | Lineage Cell Therapeutics, Inc. | 369.94M | 5.88% | 1,991,673 | 10.91M |
| 221 | AUTL | Autolus Therapeutics plc | 367.28M | 2.99% | 3,694,673 | 29.93M |
| 222 | IMRX | Immuneering Corporation | 362.91M | -5.72% | 1,417,979 | - |
| 223 | DSGN | Design Therapeutics, Inc. | 361.62M | 4.96% | 113,085 | - |
| 224 | DMAC | DiaMedica Therapeutics Inc. | 360.79M | 2.35% | 532,827 | - |
| 225 | LBRX | LB Pharmaceuticals Inc | 359.54M | 0.88% | 103,466 | - |
| 226 | DRUG | Bright Minds Biosciences Inc. | 356.76M | -4.07% | 63,766 | - |
| 227 | BNTC | Benitec Biopharma Inc. | 354.64M | 0.45% | 38,952 | - |
| 228 | DRTS | Alpha Tau Medical Ltd. | 353.35M | 1.59% | 71,915 | - |
| 229 | TVRD | Tvardi Therapeutics, Inc. | 350.72M | -2.20% | 37,984 | - |
| 230 | ALT | Altimmune, Inc. | 349.50M | 4.76% | 3,106,031 | 20.00K |
| 231 | ENGN | enGene Holdings Inc. | 348.62M | -0.15% | 42,063 | - |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 345.60M | 12.12% | 975,405 | 33.00K |
| 233 | RCKT | Rocket Pharmaceuticals, Inc. | 343.13M | 3.58% | 3,048,478 | - |
| 234 | CTMX | CytomX Therapeutics, Inc. | 339.72M | 4.04% | 3,013,533 | 141.10M |
| 235 | RAPT | RAPT Therapeutics, Inc. | 332.91M | 1.36% | 208,366 | - |
| 236 | ANNX | Annexon, Inc. | 327.46M | 4.20% | 1,802,252 | - |
| 237 | ALEC | Alector, Inc. | 321.86M | 4.95% | 1,113,351 | 81.13M |
| 238 | KRRO | Korro Bio, Inc. | 321.26M | -5.10% | 207,740 | 6.28M |
| 239 | CTNM | Contineum Therapeutics, Inc. | 316.03M | -9.84% | 157,194 | - |
| 240 | GALT | Galectin Therapeutics Inc. | 315.18M | 2.50% | 192,122 | - |
| 241 | SCPH | scPharmaceuticals Inc. | 302.68M | - | 676,225 | 49.97M |
| 242 | ALDX | Aldeyra Therapeutics, Inc. | 297.23M | 0.41% | 860,191 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 295.28M | 5.34% | 572,998 | - |
| 244 | MREO | Mereo BioPharma Group plc | 294.33M | 6.32% | 1,378,378 | 500.00K |
| 245 | OMER | Omeros Corporation | 292.64M | 2.87% | 679,039 | - |
| 246 | CADL | Candel Therapeutics, Inc. | 287.10M | 8.73% | 869,762 | - |
| 247 | LXEO | Lexeo Therapeutics, Inc. | 286.73M | 3.11% | 381,345 | - |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 281.96M | 12.41% | 1,014,900 | - |
| 249 | FHTX | Foghorn Therapeutics Inc. | 281.52M | -0.80% | 119,507 | 24.17M |
| 250 | ABEO | Abeona Therapeutics Inc. | 281.01M | 1.86% | 910,551 | 400.00K |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 280.67M | 5.79% | 468,574 | 203.47M |
| 252 | HUMA | Humacyte, Inc. | 280.32M | -4.84% | 3,631,818 | 818.00K |
| 253 | NMRA | Neumora Therapeutics, Inc. | 280.17M | -1.70% | 375,110 | - |
| 254 | CAPR | Capricor Therapeutics, Inc. | 278.42M | -8.42% | 1,418,272 | 13.39M |
| 255 | EDIT | Editas Medicine, Inc. | 269.76M | 6.01% | 2,804,900 | 38.90M |
| 256 | CLLS | Cellectis S.A. | 269.40M | 6.69% | 142,463 | 63.44M |
| 257 | FBRX | Forte Biosciences, Inc. | 263.66M | 9.44% | 42,001 | - |
| 258 | RNAC | Cartesian Therapeutics, Inc. | 261.06M | 6.36% | 72,857 | 1.03M |
| 259 | DBVT | DBV Technologies S.A. | 259.78M | - | 42,698 | 3.80M |
| 260 | ALLO | Allogene Therapeutics, Inc. | 259.60M | 0.86% | 2,595,299 | 22.00K |
| 261 | JBIO | Jade Biosciences, Inc. | 258.40M | 6.74% | 88,377 | - |
| 262 | TENX | Tenax Therapeutics, Inc. | 257.14M | 0.31% | 49,557 | - |
| 263 | CBIO | Crescent Biopharma, Inc. | 256.30M | 1.47% | 155,673 | - |
| 264 | REPL | Replimune Group, Inc. | 255.24M | 1.40% | 3,904,831 | - |
| 265 | LYEL | Lyell Immunopharma, Inc. | 253.01M | 0.61% | 163,105 | 60.00K |
| 266 | ACIU | AC Immune SA | 250.33M | 3.27% | 60,840 | 36.36M |
| 267 | IMMP | Immutep Limited | 246.58M | 6.21% | 119,449 | 3.31M |
| 268 | OABI | OmniAb, Inc. | 244.72M | 5.59% | 791,299 | 23.03M |
| 269 | AARD | Aardvark Therapeutics, Inc. | 243.66M | 3.12% | 197,969 | - |
| 270 | NGNE | Neurogene Inc. | 242.34M | -1.28% | 221,381 | 925.00K |
| 271 | FENC | Fennec Pharmaceuticals Inc. | 241.30M | - | 67,179 | 33.30M |
| 272 | HRTX | Heron Therapeutics, Inc. | 238.31M | 5.69% | 1,496,483 | 149.69M |
| 273 | SLN | Silence Therapeutics plc | 238.06M | 3.07% | 37,169 | 27.17M |
| 274 | IVVD | Invivyd, Inc. | 237.84M | - | 1,152,400 | 46.21M |
| 275 | TNXP | Tonix Pharmaceuticals Holding Corp. | 234.75M | 3.00% | 1,224,489 | 9.83M |
| 276 | VYGR | Voyager Therapeutics, Inc. | 234.08M | -1.17% | 894,771 | 42.58M |
| 277 | AVIR | Atea Pharmaceuticals, Inc. | 232.52M | 1.74% | 267,820 | - |
| 278 | EPRX | Eupraxia Pharmaceuticals Inc. | 230.94M | 11.58% | 340,491 | - |
| 279 | TNYA | Tenaya Therapeutics, Inc. | 229.80M | - | 2,785,390 | - |
| 280 | NTHI | NeOnc Technologies Holdings, Inc. | 228.76M | -0.42% | 195,703 | 59.99K |
| 281 | PRQR | ProQR Therapeutics N.V. | 227.54M | 2.86% | 227,308 | 20.13M |
| 282 | CDXS | Codexis, Inc. | 227.47M | 2.86% | 554,078 | 57.16M |
| 283 | PBYI | Puma Biotechnology, Inc. | 224.65M | 0.90% | 398,058 | 238.06M |
| 284 | SGMT | Sagimet Biosciences Inc. | 221.47M | 4.45% | 629,176 | - |
| 285 | CABA | Cabaletta Bio, Inc. | 211.28M | 5.48% | 2,814,904 | - |
| 286 | ACRS | Aclaris Therapeutics, Inc. | 209.08M | 1.05% | 1,143,179 | 16.79M |
| 287 | TLSA | Tiziana Life Sciences Ltd | 202.86M | - | 269,547 | - |
| 288 | VTYX | Ventyx Biosciences, Inc. | 201.80M | 23.04% | 2,216,016 | - |
| 289 | MIST | Milestone Pharmaceuticals Inc. | 196.79M | 4.69% | 749,579 | - |
| 290 | MDWD | MediWound Ltd. | 195.22M | 5.71% | 77,460 | 19.86M |
| 291 | BDTX | Black Diamond Therapeutics, Inc. | 194.72M | 4.27% | 1,562,730 | 70.00M |
| 292 | GNFT | Genfit S.A. | 193.04M | -4.16% | 21,234 | 53.04M |
| 293 | VOR | Vor Biopharma Inc. | 191.11M | 2.55% | 264,509 | - |
| 294 | TRDA | Entrada Therapeutics, Inc. | 187.72M | -2.58% | 375,659 | 79.48M |
| 295 | CCCC | C4 Therapeutics, Inc. | 185.76M | -17.41% | 4,005,077 | 34.24M |
| 296 | CHRS | Coherus Oncology, Inc. | 184.80M | -1.24% | 987,371 | 272.21M |
| 297 | ELTX | Elicio Therapeutics, Inc. | 181.85M | -1.59% | 54,985 | - |
| 298 | SLS | SELLAS Life Sciences Group, Inc. | 181.11M | 5.52% | 3,464,986 | - |
| 299 | CRBU | Caribou Biosciences, Inc. | 179.73M | 14.20% | 1,359,291 | 9.12M |
| 300 | IPHA | Innate Pharma S.A. | 171.38M | -2.14% | 30,903 | 14.84M |
| 301 | SGMO | Sangamo Therapeutics, Inc. | 166.24M | 0.93% | 3,572,691 | 81.71M |
| 302 | ENTA | Enanta Pharmaceuticals, Inc. | 164.61M | 0.79% | 193,476 | 64.81M |
| 303 | TVGN | Tevogen Bio Holdings Inc. | 164.33M | 10.15% | 653,495 | - |
| 304 | NVCT | Nuvectis Pharma, Inc. | 163.69M | 2.55% | 77,069 | - |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 162.65M | 7.94% | 1,160,218 | 61.95M |
| 306 | ACTU | Actuate Therapeutics, Inc. | 162.52M | 6.78% | 94,628 | - |
| 307 | GLSI | Greenwich LifeSciences, Inc. | 160.84M | 2.97% | 57,252 | - |
| 308 | VTVT | vTv Therapeutics Inc. | 158.83M | -0.95% | 4,920 | 17.00K |
| 309 | CLYM | Climb Bio, Inc. | 157.21M | 0.43% | 529,098 | - |
| 310 | ELDN | Eledon Pharmaceuticals, Inc. | 155.69M | 1.96% | 1,098,882 | - |
| 311 | AVTX | Avalo Therapeutics, Inc. | 153.88M | -1.10% | 262,056 | 441.00K |
| 312 | GNLX | Genelux Corporation | 153.47M | -1.20% | 104,387 | 8.00K |
| 313 | THTX | Theratechnologies Inc. | 152.47M | 0.30% | 654,322 | 84.38M |
| 314 | CYBN | Cybin Inc. | 152.45M | 0.83% | 466,098 | - |
| 315 | ACHV | Achieve Life Sciences, Inc. | 150.76M | 4.61% | 639,021 | - |
| 316 | NKTX | Nkarta, Inc. | 149.15M | 5.00% | 711,944 | - |
| 317 | AGEN | Agenus Inc. | 146.57M | 5.02% | 612,725 | 101.71M |
| 318 | MCRB | Seres Therapeutics, Inc. | 144.63M | -5.33% | 92,759 | - |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 141.67M | 0.52% | 149,026 | - |
| 320 | TARA | Protara Therapeutics, Inc. | 141.60M | 15.05% | 3,102,431 | - |
| 321 | CRDF | Cardiff Oncology, Inc. | 137.71M | 0.98% | 652,334 | 545.00K |
| 322 | ZURA | Zura Bio Limited | 137.19M | 6.03% | 313,617 | - |
| 323 | PYXS | Pyxis Oncology, Inc. | 134.58M | -3.56% | 649,829 | 2.82M |
| 324 | CGEN | Compugen Ltd. | 133.76M | 7.52% | 670,595 | 22.14M |
| 325 | MOLN | Molecular Partners AG | 132.88M | -2.65% | 10,985 | 856.30K |
| 326 | INO | Inovio Pharmaceuticals, Inc. | 132.33M | 8.26% | 846,221 | 182.34K |
| 327 | OBIO | Orchestra BioMed Holdings, Inc. | 132.19M | 0.41% | 290,710 | 2.94M |
| 328 | TIL | Instil Bio, Inc. | 130.76M | -2.81% | 128,606 | - |
| 329 | ONCY | Oncolytics Biotech Inc. | 130.47M | -4.41% | 586,162 | - |
| 330 | KALA | KALA BIO, Inc. | 130.24M | -5.50% | 238,218 | - |
| 331 | SEER | Seer, Inc. | 129.87M | -0.90% | 59,130 | 16.29M |
| 332 | ACOG | Alpha Cognition Inc. | 129.29M | -0.25% | 57,879 | 4.59M |
| 333 | HURA | TuHURA Biosciences, Inc. | 127.62M | -2.30% | 228,957 | - |
| 334 | CGTX | Cognition Therapeutics, Inc. | 126.16M | 2.14% | 2,157,346 | - |
| 335 | IKT | Inhibikase Therapeutics, Inc. | 125.19M | 2.44% | 104,248 | 1.00 |
| 336 | EXOZ | eXoZymes, Inc. | 123.71M | 1.94% | 7,206 | -700.00 |
| 337 | BMEA | Biomea Fusion, Inc. | 120.80M | 4.10% | 673,269 | - |
| 338 | SKYE | Skye Bioscience, Inc. | 120.54M | -2.75% | 418,236 | - |
| 339 | FBIO | Fortress Biotech, Inc. | 119.02M | 8.99% | 1,492,771 | 59.30M |
| 340 | STTK | Shattuck Labs, Inc. | 117.36M | 7.46% | 342,739 | 3.00M |
| 341 | FATE | Fate Therapeutics, Inc. | 116.48M | 4.96% | 1,445,928 | 8.47M |
| 342 | ANIX | Anixa Biosciences, Inc. | 114.88M | 5.76% | 267,511 | - |
| 343 | SPRO | Spero Therapeutics, Inc. | 114.24M | 1.50% | 345,958 | 48.58M |
| 344 | SAVA | Cassava Sciences, Inc. | 112.07M | 1.75% | 13,517,869 | - |
| 345 | ZNTL | Zentalis Pharmaceuticals, Inc. | 109.65M | - | 353,969 | 26.87M |
| 346 | ARMP | Armata Pharmaceuticals, Inc. | 109.41M | -1.63% | 6,724 | 6.87M |
| 347 | MGNX | MacroGenics, Inc. | 109.35M | 6.79% | 399,322 | 165.50M |
| 348 | IRD | Opus Genetics, Inc. | 107.81M | 12.50% | 714,689 | 15.42M |
| 349 | ANRO | Alto Neuroscience, Inc. | 107.76M | 10.56% | 126,534 | - |
| 350 | ATOS | Atossa Therapeutics, Inc. | 107.33M | -2.10% | 468,613 | - |
| 351 | SRZN | Surrozen, Inc. | 104.56M | -0.65% | 47,755 | 12.62M |
| 352 | ATYR | aTyr Pharma, Inc. | 102.89M | 5.84% | 21,352,835 | 235.00K |
| 353 | VTGN | Vistagen Therapeutics, Inc. | 102.17M | 11.74% | 3,519,202 | 646.00K |
| 354 | ANEB | Anebulo Pharmaceuticals, Inc. | 101.89M | -1.59% | 47,706 | - |
| 355 | ORMP | Oramed Pharmaceuticals Inc. | 101.28M | 5.56% | 109,548 | 2.00M |
| 356 | TCRX | TScan Therapeutics, Inc. | 101.01M | -0.56% | 166,809 | 6.96M |
| 357 | PTHS | Pelthos Therapeutics Inc. | 100.88M | -1.89% | 14,488 | - |
| 358 | IOBT | IO Biotech, Inc. | 98.16M | -4.49% | 805,670 | - |
| 359 | ADAG | Adagene Inc. | 94.73M | -1.95% | 65,769 | 103.20K |
| 360 | CSBR | Champions Oncology, Inc. | 93.07M | 2.74% | 38,381 | 56.88M |
| 361 | HYFT | MindWalk Holdings Corp. | 92.78M | 16.18% | 2,443,347 | 18.21M |
| 362 | PLRX | Pliant Therapeutics, Inc. | 92.08M | 4.90% | 222,290 | - |
| 363 | VANI | Vivani Medical, Inc. | 91.83M | 9.93% | 625,652 | - |
| 364 | OVID | Ovid Therapeutics Inc. | 91.73M | 6.61% | 1,343,551 | 6.65M |
| 365 | COYA | Coya Therapeutics, Inc. | 91.49M | -0.55% | 52,276 | 423.45K |
| 366 | IFRX | InflaRx N.V. | 91.46M | 0.75% | 389,594 | 191.22K |
| 367 | NAUT | Nautilus Biotechnology, Inc. | 89.71M | 4.30% | 555,766 | - |
| 368 | IMUX | Immunic, Inc. | 89.65M | 7.55% | 1,934,802 | - |
| 369 | WHWK | Whitehawk Therapeutics, Inc. | 89.54M | -1.04% | 47,033 | 21.60M |
| 370 | IMA | ImageneBio, Inc. | 89.45M | -3.03% | 35,989 | 4.30M |
| 371 | CNTX | Context Therapeutics Inc. | 88.95M | 2.42% | 265,638 | - |
| 372 | CNTB | Connect Biopharma Holdings Limited | 88.04M | 0.64% | 59,045 | 1.97M |
| 373 | MGX | Metagenomi, Inc. | 87.83M | 14.15% | 660,793 | 33.77M |
| 374 | NTRB | Nutriband Inc. | 87.60M | 0.97% | 24,034 | 2.58M |
| 375 | VXRT | Vaxart, Inc. | 87.51M | -1.03% | 681,370 | 80.72M |
| 376 | QNCX | Quince Therapeutics, Inc. | 87.02M | 1.25% | 245,627 | - |
| 377 | ATRA | Atara Biotherapeutics, Inc. | 86.39M | 2.07% | 54,082 | 188.67M |
| 378 | EQ | Equillium, Inc. | 86.28M | -0.68% | 1,259,322 | 16.55M |
| 379 | OKYO | OKYO Pharma Limited | 84.62M | 13.64% | 209,769 | - |
| 380 | HOWL | Werewolf Therapeutics, Inc. | 84.14M | 23.49% | 2,528,504 | 1.14M |
| 381 | XBIT | XBiotech Inc. | 83.84M | 1.10% | 170,144 | - |
| 382 | ENTX | Entera Bio Ltd. | 82.65M | 0.56% | 53,552 | 166.00K |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 82.29M | -3.08% | 215,470 | - |
| 384 | ATHE | Alterity Therapeutics Limited | 78.81M | -1.12% | 5,051 | 3.57M |
| 385 | SLGL | Sol-Gel Technologies Ltd. | 78.03M | -8.16% | 14,517 | 23.93M |
| 386 | ABOS | Acumen Pharmaceuticals, Inc. | 77.53M | 1.59% | 204,025 | - |
| 387 | XFOR | X4 Pharmaceuticals, Inc. | 75.91M | 6.62% | 472,215 | 32.77M |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 75.87M | 13.40% | 122,154 | 263.56K |
| 389 | CRVO | CervoMed Inc. | 75.50M | 4.75% | 100,219 | 7.78M |
| 390 | STRO | Sutro Biopharma, Inc. | 75.46M | 0.39% | 187,428 | 104.47M |
| 391 | RPTX | Repare Therapeutics Inc. | 73.89M | 0.58% | 58,630 | 250.00K |
| 392 | CBUS | Cibus, Inc. | 73.76M | -4.23% | 141,119 | 4.85M |
| 393 | INKT | MiNK Therapeutics, Inc. | 73.72M | 8.02% | 113,893 | - |
| 394 | IMMX | Immix Biopharma, Inc. | 73.17M | 2.28% | 91,791 | - |
| 395 | ADVM | Adverum Biotechnologies, Inc. | 72.61M | -7.98% | 846,412 | 1.00M |
| 396 | NSRX | Nasus Pharma Ltd. | 72.48M | -0.12% | 6,689 | - |
| 397 | BYSI | BeyondSpring Inc. | 72.19M | -6.77% | 76,762 | 1.88M |
| 398 | CVM | CEL-SCI Corporation | 71.86M | 3.69% | 167,895 | - |
| 399 | GUTS | Fractyl Health, Inc. | 71.59M | 0.32% | 739,338 | 17.00K |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 71.01M | 2.29% | 582,106 | - |
| 401 | QNTM | Quantum BioPharma Ltd. | 70.45M | -2.01% | 89,000 | - |
| 402 | UNCY | Unicycive Therapeutics, Inc. | 69.94M | - | 461,097 | - |
| 403 | OSTX | OS Therapies Incorporated | 69.94M | 4.25% | 306,895 | - |
| 404 | PEPG | PepGen Inc. | 69.54M | 12.77% | 645,812 | - |
| 405 | APLT | Applied Therapeutics, Inc. | 68.52M | 9.45% | 1,414,278 | 121.00K |
| 406 | ACET | Adicet Bio, Inc. | 68.33M | 3.26% | 268,121 | - |
| 407 | NRXP | NRx Pharmaceuticals, Inc. | 68.22M | -3.37% | 208,415 | - |
| 408 | ALXO | ALX Oncology Holdings Inc. | 68.01M | 4.96% | 739,128 | - |
| 409 | ARTV | Artiva Biotherapeutics, Inc. | 65.95M | -6.25% | 95,464 | 251.00K |
| 410 | ABVC | ABVC BioPharma, Inc. | 65.47M | 1.06% | 67,445 | 391.24K |
| 411 | MNOV | MediciNova, Inc. | 62.78M | 0.79% | 32,473 | 134.60K |
| 412 | GANX | Gain Therapeutics, Inc. | 62.55M | 10.13% | 864,594 | - |
| 413 | ANL | Adlai Nortye Ltd. | 62.36M | -4.30% | 37,933 | 1.94M |
| 414 | ALGS | Aligos Therapeutics, Inc. | 58.62M | -1.45% | 31,743 | 3.17M |
| 415 | HYPD | Hyperion DeFi, Inc. | 57.86M | -9.93% | 913,580 | 44.44K |
| 416 | DTIL | Precision BioSciences, Inc. | 57.28M | 1.67% | 83,886 | 1.26M |
| 417 | PRLD | Prelude Therapeutics Incorporated | 57.17M | 2.56% | 180,259 | 7.00M |
| 418 | CELU | Celularity Inc. | 56.59M | -4.50% | 137,651 | 44.59M |
| 419 | ICCC | ImmuCell Corporation | 56.45M | 4.70% | 6,898 | 28.27M |
| 420 | PYPD | PolyPid Ltd. | 55.57M | 2.90% | 48,542 | - |
| 421 | CAMP | Camp4 Therapeutics Corporation | 55.44M | 20.61% | 277,838 | 3.01M |
| 422 | RLMD | Relmada Therapeutics, Inc. | 54.77M | 7.84% | 397,506 | - |
| 423 | BTAI | BioXcel Therapeutics, Inc. | 54.62M | -7.02% | 1,521,378 | 868.00K |
| 424 | CUE | Cue Biopharma, Inc. | 54.10M | 4.75% | 129,926 | 8.29M |
| 425 | GNTA | Genenta Science S.p.A. | 53.77M | 2.80% | 2,098 | - |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 52.78M | 1.96% | 876,907 | - |
| 427 | INMB | INmune Bio, Inc. | 52.64M | 4.21% | 515,125 | 50.00K |
| 428 | VERU | Veru Inc. | 52.30M | 2.88% | 89,752 | 16.89M |
| 429 | ACRV | Acrivon Therapeutics, Inc. | 52.22M | 1.84% | 505,047 | - |
| 430 | SER | Serina Therapeutics, Inc. | 52.18M | 1.19% | 32,060 | 130.00K |
| 431 | ATNM | Actinium Pharmaceuticals, Inc. | 50.85M | 2.52% | 141,493 | 81.00K |
| 432 | PDSB | PDS Biotechnology Corporation | 50.79M | 2.86% | 372,452 | - |
| 433 | KPTI | Karyopharm Therapeutics Inc. | 50.73M | 8.13% | 149,628 | 137.27M |
| 434 | MAIA | MAIA Biotechnology, Inc. | 50.15M | -1.94% | 168,324 | - |
| 435 | FGEN | FibroGen, Inc. | 49.46M | 8.13% | 39,996 | 7.35M |
| 436 | RNXT | RenovoRx, Inc. | 47.64M | -2.26% | 808,077 | 662.00K |
| 437 | RADX | Radiopharm Theranostics Limited | 46.74M | -6.78% | 18,408 | 8.20M |
| 438 | JUNS | Jupiter Neurosciences, Inc. | 45.98M | -7.69% | 131,651 | - |
| 439 | ANVS | Annovis Bio, Inc. | 45.21M | - | 170,491 | - |
| 440 | CALC | CalciMedica, Inc. | 45.13M | 6.95% | 26,078 | - |
| 441 | BRNS | Barinthus Biotherapeutics plc | 44.99M | 2.22% | 11,215 | 14.97M |
| 442 | LTRN | Lantern Pharma Inc. | 44.93M | 3.23% | 72,717 | - |
| 443 | ADAP | Adaptimmune Therapeutics plc | 44.37M | 15.93% | 159,977,970 | 65.09M |
| 444 | GRCE | Grace Therapeutics, Inc. | 43.01M | 0.32% | 46,748 | - |
| 445 | OTLK | Outlook Therapeutics, Inc. | 43.00M | 0.52% | 1,209,843 | 1.51M |
| 446 | ESLA | Estrella Immunopharma, Inc. | 43.00M | 4.50% | 60,869 | - |
| 447 | VRCA | Verrica Pharmaceuticals Inc. | 42.13M | 1.59% | 272,132 | 14.70M |
| 448 | PSTV | Plus Therapeutics, Inc. | 42.02M | 1.85% | 5,635,790 | 5.32M |
| 449 | TPST | Tempest Therapeutics, Inc. | 41.96M | -6.71% | 89,863 | - |
| 450 | IPSC | Century Therapeutics, Inc. | 41.47M | 0.59% | 320,811 | 114.13M |
| 451 | JSPR | Jasper Therapeutics, Inc. | 41.28M | 1.60% | 442,207 | - |
| 452 | LVTX | LAVA Therapeutics N.V. | 41.04M | 5.05% | 278,602 | 4.99M |
| 453 | XLO | Xilio Therapeutics, Inc. | 39.65M | -1.92% | 164,603 | 15.00M |
| 454 | APLM | Apollomics, Inc. | 39.56M | 0.02% | 682,277 | 198.00K |
| 455 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 39.05M | -7.74% | 1,144,976 | 1.00M |
| 456 | GBIO | Generation Bio Co. | 39.00M | 0.70% | 37,689 | 21.23M |
| 457 | PLUR | Pluri Inc. | 38.41M | 2.39% | 2,888 | 1.34M |
| 458 | RENB | Lunai Bioworks Inc. | 37.34M | -7.60% | 11,455,322 | - |
| 459 | DYAI | Dyadic International, Inc. | 37.27M | -3.74% | 113,742 | 4.14M |
| 460 | LIMN | Liminatus Pharma, Inc. | 37.20M | 13.49% | 1,697,883 | - |
| 461 | BCAB | BioAtla, Inc. | 36.73M | 0.58% | 869,760 | 11.00M |
| 462 | MRSN | Mersana Therapeutics, Inc. | 36.68M | 1.38% | 43,084 | 34.77M |
| 463 | ANTX | AN2 Therapeutics, Inc. | 36.62M | 1.52% | 34,674 | - |
| 464 | IGC | IGC Pharma, Inc. | 36.38M | -2.15% | 395,059 | 1.33M |
| 465 | SNTI | Senti Biosciences, Inc. | 36.36M | 2.96% | 387,775 | - |
| 466 | MURA | Mural Oncology plc | 35.86M | -0.48% | 121,065 | - |
| 467 | RANI | Rani Therapeutics Holdings, Inc. | 35.68M | -3.59% | 403,499 | 1.20M |
| 468 | OKUR | OnKure Therapeutics, Inc. | 35.31M | 1.56% | 84,860 | - |
| 469 | KLTO | Klotho Neurosciences, Inc. | 33.76M | -0.31% | 1,266,931 | - |
| 470 | NRSN | NeuroSense Therapeutics Ltd. | 31.81M | 4.10% | 136,954 | - |
| 471 | CLGN | CollPlant Biotechnologies Ltd. | 31.68M | -0.93% | 10,085 | 2.40M |
| 472 | ITRM | Iterum Therapeutics plc | 30.36M | 1.48% | 544,251 | - |
| 473 | KZR | Kezar Life Sciences, Inc. | 27.97M | 1.60% | 69,224 | - |
| 474 | ICU | SeaStar Medical Holding Corporation | 27.91M | 10.90% | 2,117,026 | 766.00K |
| 475 | RNTX | Rein Therapeutics Inc. | 27.50M | -2.48% | 426,072 | - |
| 476 | DARE | Daré Bioscience, Inc. | 26.89M | -3.77% | 131,926 | -17.70K |
| 477 | CVKD | Cadrenal Therapeutics, Inc. | 26.73M | -0.84% | 22,916 | - |
| 478 | AKTX | Akari Therapeutics, Plc | 26.71M | 0.82% | 25,764 | - |
| 479 | NRXS | NeurAxis, Inc. | 26.56M | 5.91% | 87,661 | 3.22M |
| 480 | LEXX | Lexaria Bioscience Corp. | 26.40M | 8.87% | 166,643 | 615.92K |
| 481 | PPCB | Propanc Biopharma, Inc. | 26.03M | -5.56% | 202,001 | - |
| 482 | CASI | CASI Pharmaceuticals, Inc. | 25.87M | -6.18% | 32,683 | 31.56M |
| 483 | SABS | SAB Biotherapeutics, Inc. | 25.82M | 0.40% | 162,145 | 114.70K |
| 484 | HOTH | Hoth Therapeutics, Inc. | 25.72M | 7.78% | 1,009,279 | - |
| 485 | RLYB | Rallybio Corporation | 25.45M | 3.48% | 547,524 | 761.00K |
| 486 | BOLD | Boundless Bio, Inc. | 25.29M | -0.88% | 95,816 | - |
| 487 | ENLV | Enlivex Therapeutics Ltd. | 25.18M | 0.99% | 74,894 | - |
| 488 | MTVA | MetaVia Inc. | 24.92M | -0.96% | 470,903 | - |
| 489 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.72M | -0.55% | 103,677 | - |
| 490 | PASG | Passage Bio, Inc. | 23.97M | 5.16% | 26,288 | - |
| 491 | KAPA | Kairos Pharma, Ltd. | 23.86M | -5.74% | 942,262 | - |
| 492 | XCUR | Exicure, Inc. | 23.50M | -3.12% | 22,387 | 500.00K |
| 493 | NNVC | NanoViricides, Inc. | 23.22M | -1.70% | 247,070 | - |
| 494 | CLSD | Clearside Biomedical, Inc. | 22.98M | 16.76% | 108,393 | 4.17M |
| 495 | QTTB | Q32 Bio Inc. | 22.81M | 1.08% | 52,204 | - |
| 496 | ALLR | Allarity Therapeutics, Inc. | 22.74M | 15.58% | 2,192,815 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 22.27M | 3.49% | 1,896 | 368.84K |
| 498 | PMN | ProMIS Neurosciences, Inc. | 22.22M | -2.83% | 532,766 | - |
| 499 | FBLG | FibroBiologics, Inc. | 22.13M | -0.77% | 514,334 | - |
| 500 | CING | Cingulate Inc. | 21.42M | 7.91% | 231,618 | - |
| 501 | CRIS | Curis, Inc. | 21.00M | -1.18% | 54,904 | 11.41M |
| 502 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 20.90M | 15.27% | 18,682,305 | - |
| 503 | ASBP | Aspire Biopharma Holdings, Inc. | 20.80M | 1.89% | 663,580 | - |
| 504 | SYBX | Synlogic, Inc. | 20.16M | -3.21% | 15,867 | 8.00K |
| 505 | LSTA | Lisata Therapeutics, Inc. | 20.05M | -1.72% | 41,998 | 1.07M |
| 506 | CTXR | Citius Pharmaceuticals, Inc. | 19.73M | -2.52% | 358,245 | - |
| 507 | EVAX | Evaxion A/S | 19.27M | -1.17% | 115,735 | 3.18M |
| 508 | ABP | Abpro Holdings, Inc. | 19.05M | -2.62% | 8,171,892 | 183.00K |
| 509 | NEUP | Neuphoria Therapeutics Inc. | 18.54M | -2.38% | 56,216 | 15.66M |
| 510 | PULM | Pulmatrix, Inc. | 17.71M | -2.61% | 41,402 | 369.00K |
| 511 | CLRB | Cellectar Biosciences, Inc. | 17.56M | 5.77% | 63,432 | - |
| 512 | EDSA | Edesa Biotech, Inc. | 17.24M | -0.81% | 8,907 | - |
| 513 | COCP | Cocrystal Pharma, Inc. | 16.95M | -2.26% | 777,484 | - |
| 514 | GOVX | GeoVax Labs, Inc. | 16.66M | 1.47% | 545,617 | 6.14M |
| 515 | BCTX | BriaCell Therapeutics Corp. | 16.49M | 2.73% | 88,610 | - |
| 516 | LGVN | Longeveron Inc. | 16.21M | -1.96% | 380,916 | 2.07M |
| 517 | BLRX | BioLineRx Ltd. | 16.09M | 2.93% | 19,943 | 17.25M |
| 518 | THAR | Tharimmune, Inc. | 16.02M | -19.17% | 1,047,111 | - |
| 519 | IBIO | iBio, Inc. | 15.94M | -5.62% | 588,908 | 400.00K |
| 520 | OSRH | OSR Holdings, Inc. | 15.88M | -2.72% | 94,286 | 104.74K |
| 521 | LPCN | Lipocine Inc. | 15.50M | -0.69% | 11,775 | 4.21M |
| 522 | NXTC | NextCure, Inc. | 15.33M | 1.60% | 3,911 | - |
| 523 | ATHA | Athira Pharma, Inc. | 15.22M | -0.26% | 18,805 | - |
| 524 | MBRX | Moleculin Biotech, Inc. | 15.00M | 1.37% | 2,316,418 | - |
| 525 | NERV | Minerva Neurosciences, Inc. | 14.62M | 2.96% | 9,345 | - |
| 526 | IMRN | Immuron Limited | 14.31M | 2.11% | 40,355 | 4.78M |
| 527 | BIVI | BioVie Inc. | 14.24M | 1.61% | 231,163 | - |
| 528 | PHGE | BiomX Inc. | 14.21M | -0.19% | 363,546 | - |
| 529 | CANF | Can-Fite BioPharma Ltd. | 14.18M | -1.90% | 284,154 | 560.00K |
| 530 | CMMB | Chemomab Therapeutics Ltd. | 13.61M | -0.75% | 121,947 | - |
| 531 | TRAW | Traws Pharma, Inc. | 13.49M | -5.91% | 82,511 | 2.90M |
| 532 | PLRZ | Polyrizon Ltd. | 13.38M | 0.89% | 474,609 | - |
| 533 | IMNN | Imunon, Inc. | 12.98M | 3.41% | 1,209,529 | - |
| 534 | PHIO | Phio Pharmaceuticals Corp. | 12.83M | 8.21% | 113,340 | - |
| 535 | LPTX | Leap Therapeutics, Inc. | 12.75M | 6.18% | 871,813 | - |
| 536 | INTS | Intensity Therapeutics, Inc. | 12.74M | 4.59% | 1,932,484 | - |
| 537 | APM | Aptorum Group Limited | 12.50M | -1.69% | 93,620 | - |
| 538 | NBY | NovaBay Pharmaceuticals, Inc. | 12.29M | 15.93% | 778,716 | 9.78M |
| 539 | CARM | Carisma Therapeutics, Inc. | 12.28M | 17.51% | 1,285,710 | 10.77M |
| 540 | ARTL | Artelo Biosciences, Inc. | 11.90M | 4.80% | 109,291 | - |
| 541 | BRTX | BioRestorative Therapies, Inc. | 11.89M | 2.76% | 18,330 | 605.20K |
| 542 | MBIO | Mustang Bio, Inc. | 11.80M | -2.40% | 141,212 | - |
| 543 | BCDA | BioCardia, Inc. | 11.77M | -4.31% | 794,962 | 3.00K |
| 544 | MRKR | Marker Therapeutics, Inc. | 11.65M | -5.26% | 369,407 | 5.39M |
| 545 | MTNB | Matinas BioPharma Holdings, Inc. | 11.44M | 17.71% | 126,704 | - |
| 546 | XTLB | XTL Biopharmaceuticals Ltd. | 11.36M | -0.66% | 7,856 | 451.00K |
| 547 | SNSE | Sensei Biotherapeutics, Inc. | 11.29M | -0.56% | 2,320 | - |
| 548 | LYRA | Lyra Therapeutics, Inc. | 10.56M | 1.10% | 11,675 | 770.00K |
| 549 | EVGN | Evogene Ltd. | 10.33M | -0.93% | 85,198 | 9.44M |
| 550 | EPIX | ESSA Pharma Inc. | 10.27M | 2.75% | 2,638,663 | - |
| 551 | BOLT | Bolt Biotherapeutics, Inc. | 10.25M | 2.10% | 17,867 | 4.17M |
| 552 | SNGX | Soligenix, Inc. | 9.99M | -13.38% | 351,253 | 2.34K |
| 553 | PCSA | Processa Pharmaceuticals, Inc. | 9.95M | 2.17% | 1,534,839 | - |
| 554 | DWTX | Dogwood Therapeutics, Inc. | 9.90M | 3.39% | 22,401 | - |
| 555 | GNPX | Genprex, Inc. | 9.87M | -1.12% | 2,322,254 | - |
| 556 | CYCN | Cyclerion Therapeutics, Inc. | 9.74M | 27.73% | 108,236 | 2.17M |
| 557 | VIVS | VivoSim Labs, Inc. | 9.67M | -10.36% | 125,018 | 142.00K |
| 558 | INAB | IN8bio, Inc. | 9.58M | 5.50% | 73,915 | - |
| 559 | RNAZ | TransCode Therapeutics, Inc. | 9.48M | -2.69% | 5,605 | - |
| 560 | QLGN | Qualigen Therapeutics, Inc. | 9.38M | 94.72% | 60,410,866 | - |
| 561 | ERNA | Ernexa Therapeutics Inc. | 9.28M | -9.02% | 196,629 | 488.00K |
| 562 | CELZ | Creative Medical Technology Holdings, Inc. | 8.98M | -0.85% | 14,131 | 6.00K |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 8.96M | 3.16% | 18,123 | 20.00K |
| 564 | AEON | AEON Biopharma, Inc. | 8.95M | 0.75% | 109,568 | - |
| 565 | APRE | Aprea Therapeutics, Inc. | 8.56M | 2.08% | 38,683 | 841.01K |
| 566 | KZIA | Kazia Therapeutics Limited | 8.41M | -3.09% | 29,586 | 1.55M |
| 567 | PTIX | Protagenic Therapeutics, Inc. | 8.37M | 7.90% | 142,993 | - |
| 568 | IBO | Impact BioMedical Inc. | 8.16M | -1.24% | 182,584 | 7.00K |
| 569 | VYNE | VYNE Therapeutics Inc. | 8.15M | 5.19% | 1,728,079 | 476.00K |
| 570 | ADXN | Addex Therapeutics Ltd | 8.08M | 7.45% | 4,571 | 278.51K |
| 571 | GLMD | Galmed Pharmaceuticals Ltd. | 8.05M | 0.68% | 60,655 | - |
| 572 | ENTO | Entero Therapeutics, Inc. | 7.93M | -3.29% | 202,711 | - |
| 573 | NCNA | NuCana plc | 7.65M | 8.67% | 264,576 | - |
| 574 | ADIL | Adial Pharmaceuticals, Inc. | 7.50M | -1.83% | 460,847 | - |
| 575 | ALZN | Alzamend Neuro, Inc. | 7.44M | -1.25% | 68,146 | - |
| 576 | SILO | Silo Pharma, Inc. | 7.41M | 14.53% | 1,088,484 | 72.10K |
| 577 | HCWB | HCW Biologics Inc. | 7.33M | -4.49% | 111,526 | 832.84K |
| 578 | NLSP | NLS Pharmaceutics AG | 6.98M | 8.33% | 231,854 | - |
| 579 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.89M | -2.01% | 23,786 | 19.51K |
| 580 | PMCB | PharmaCyte Biotech, Inc. | 6.80M | 2.03% | 78,009 | - |
| 581 | CERO | CERo Therapeutics Holdings, Inc. | 6.62M | 1.67% | 73,153 | - |
| 582 | TNFA | TNF Pharmaceuticals, Inc. | 6.55M | -3.89% | 226,485 | - |
| 583 | ENSC | Ensysce Biosciences, Inc. | 6.50M | 2.82% | 189,766 | 7.41M |
| 584 | CLDI | Calidi Biotherapeutics, Inc. | 6.48M | 4.55% | 100,793 | - |
| 585 | ACXP | Acurx Pharmaceuticals, Inc. | 6.47M | -0.49% | 69,852 | - |
| 586 | CMND | Clearmind Medicine Inc. | 6.01M | -7.56% | 930,896 | - |
| 587 | PALI | Palisade Bio, Inc. | 5.79M | 5.80% | 527,658 | - |
| 588 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.66M | 1.47% | 27,294 | 984.49K |
| 589 | TTNP | Titan Pharmaceuticals, Inc. | 5.60M | -2.32% | 951 | - |
| 590 | APVO | Aptevo Therapeutics Inc. | 5.56M | -3.98% | 2,711,726 | - |
| 591 | OGEN | Oragenics, Inc. | 5.53M | 12.61% | 237,654 | - |
| 592 | TCRT | Alaunos Therapeutics, Inc. | 5.47M | 2.48% | 22,727 | 6.00K |
| 593 | KTTA | Pasithea Therapeutics Corp. | 5.43M | -0.48% | 54,446 | - |
| 594 | ADTX | Aditxt, Inc. | 5.13M | 6.19% | 111,911 | 12.05K |
| 595 | SPRB | Spruce Biosciences, Inc. | 5.11M | 8.35% | 16,437 | 1.30M |
| 596 | GRI | GRI Bio, Inc. | 5.03M | 10.50% | 1,911,102 | - |
| 597 | CNSP | CNS Pharmaceuticals, Inc. | 4.87M | 6.27% | 18,263 | - |
| 598 | MLEC | Moolec Science SA | 4.86M | 3.42% | 25,137 | 7.83M |
| 599 | XBIO | Xenetic Biosciences, Inc. | 4.81M | -0.32% | 8,416 | 2.45M |
| 600 | PPBT | Purple Biotech Ltd | 4.78M | -2.69% | 229,719 | - |
| 601 | ONCO | Onconetix, Inc. | 4.73M | 3.03% | 2,591,755 | 1.33M |
| 602 | JAGX | Jaguar Health, Inc. | 4.41M | 9.14% | 72,696 | 11.81M |
| 603 | XRTX | XORTX Therapeutics Inc. | 4.20M | 4.69% | 51,311 | - |
| 604 | QNRX | Quoin Pharmaceuticals, Ltd. | 4.12M | -8.96% | 61,419 | - |
| 605 | BDRX | Biodexa Pharmaceuticals Plc | 4.10M | 0.08% | 10,937 | 104.90K |
| 606 | GLTO | Galecto, Inc. | 3.97M | 4.53% | 18,056 | - |
| 607 | TOVX | Theriva Biologics, Inc. | 3.88M | 2.28% | 244,050 | - |
| 608 | DRMA | Dermata Therapeutics, Inc. | 3.67M | -0.92% | 10,972 | - |
| 609 | REVB | Revelation Biosciences, Inc. | 3.56M | -1.30% | 235,964 | - |
| 610 | INDP | Indaptus Therapeutics, Inc. | 3.14M | 2.16% | 335,226 | - |
| 611 | GTBP | GT Biopharma, Inc. | 2.85M | 2.26% | 134,521 | - |
| 612 | VRAX | Virax Biolabs Group Limited | 2.69M | -1.32% | 116,180 | 6.33K |
| 613 | PBM | Psyence Biomedical Ltd. | 2.65M | -4.62% | 109,815 | - |
| 614 | AZTR | Azitra, Inc. | 2.65M | -0.85% | 131,407 | 7.50K |
| 615 | ELAB | PMGC Holdings Inc. | 2.39M | -3.26% | 24,324 | -605.53K |
| 616 | CDT | CDT Equity Inc. | 2.30M | 4.38% | 1,997,964 | - |
| 617 | SCNI | Scinai Immunotherapeutics Ltd. | 2.20M | -7.64% | 189,146 | 1.15M |
| 618 | SLRX | Salarius Pharmaceuticals, Inc. | 2.14M | -2.89% | 76,520 | - |
| 619 | SPRC | SciSparc Ltd. | 2.12M | -16.77% | 489,878 | 1.31M |
| 620 | SLXN | Silexion Therapeutics Corp | 2.04M | 3.71% | 231,212 | - |
| 621 | ENVB | Enveric Biosciences, Inc. | 1.89M | -3.26% | 652,762 | - |